Skip to content
naulon
Get started
Not checkedNot checked for notices yet.

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia

Shilpa Sampathi, Yelena Chernyavskaya, Meghan G. Haney and 14 more

Frontiers in Oncology · 2022

doi:10.3389/fonc.2022.958673 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References51

  1. 14.

    Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma · 2015

  2. 18.
    Corrected

    The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community · 2016

  3. 24.

    Acute lymphoblastic leukemia: a comprehensive review and 2017 update · 2017

  4. 27.

    The potential of liquid biopsies for the early detection of cancer · 2017

  5. 38.

    Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study · 2019

  6. 44.

    Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma · 2020

  7. 46.

    Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin · 2020

44 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.